Journal ArticleOPEN ACCESS

Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn’s Disease, and Relapsing Multiple Sclerosis

Inflammatory Bowel Diseases (2024) 30(12) 2512-2515
DOI: 10.1093/ibd/izae011
17Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study evaluated pregnancy outcomes in patients with ulcerative colitis, Crohn’s disease, or multiple sclerosis and in healthy volunteers treated with ozanimod.There was no increased incidence of fetal abnormalities or adverse pregnancy outcomes with ozanimod exposure during early pregnancy.

Author supplied keywords

Cite

CITATION STYLE

APA

Dubinsky, M. C., Charles, L., Selmaj, K. W., Comi, G., Krakovich, A., Rosen, M., … Mahadevan, U. (2024). Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn’s Disease, and Relapsing Multiple Sclerosis. Inflammatory Bowel Diseases, 30(12), 2512–2515. https://doi.org/10.1093/ibd/izae011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free